Today's Big Gainers: SAY, AAI, SNTS, NWY
Wednesday, December 2, 4:11 PM ET

Satyam's stock seems to be responding positively to their statement, with shares up over 10% so far today.

AirTran Airways, a subsidiary of AirTran Holdings (AAI), reported traffic for the month of November. The airline reported that revenue passenger miles and available seat miles represent new monthly records for the month of November. For November, traffic grew by 10.5 percent to more than 1.4 billion RPMs and the airline enplaned nearly 2 million passengers.

Shares of Airtran are up about six and three quarters percent on the report.

Santarus (NASDAQ:SNTS), a specialty biopharmaceutical company, announced that the FDA approved Schering-Plough HealthCare Products' New Drug Application for ZEGERID OTC Capsules with a dosage strength for over-the-counter treatment of frequent heartburn. Merck bought Schering-Plough in November. The OTC heartburn market in the U.S. is estimated at $1.7 billion based on data from Information Resources, Inc., a market research firm, and company estimates.

The New Drug Application was submitted by Schering-Plough under the terms of a license agreement for OTC proton pump inhibitor products using Santarus’ proprietary technology.

Shares of Santarus are up over 22.5% on the news.

New York & Company (NYSE:NWY), a specialty retailer of women?s apparel in the United States, was upgraded this morning by Auriga USA.

The upgrade has shares higher today, currently up over 12%.